Intestinal Trefoil Factor 3: a new biological factor mediating gut-kidney crosstalk in Diabetic kidney disease-Reference-Cited by-同舟云学术

Intestinal Trefoil Factor 3: a new biological factor mediating gut-kidney crosstalk in Diabetic kidney disease

Published:2023-08-07 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Zhang Tao¹,Zhang Yinghui¹,Tao Jie¹,Rong Xianglu¹,Yang Yiqi¹

Affiliation:

1. Guangdong Pharmaceutical University

Abstract

Abstract Purpose To investigate the effect of TFF3 in the pathogenesis of Diabetic Kidney Disease (DKD), and explore the changes of TFF3 dynamic expression pattern in renal injury process. Methods DKD animal model was established by streptozotocin (STZ) (40 mg/kg/d, ip, for 5 days, consecutively) combined with the high fat diet (HFD) for 12 weeks. While animals were sacrificed at different time stages in DKD process (at 4 weeks, 8 weeks and 12 weeks, respectively). Results STZ combined with high-fat diet induced weight gain, increased blood glucose and decreased glucose tolerance in DKD mice; compared to the control group, the DKD group exhibits amount of glycogen and collagen fibers accumulation (P < 0.05) and the renal injury was aggravated in a time-dependent manner. The TFF3 expression level was decreased in kidney, and increased in colon tissue. Conclusion TFF3 is not only expressed in colon, but also expressed in renal medulla and cortex. TFF3 might be play a pivotal role in renal mucosal repair by gut-kidney crosstalk, and protect renal from high glucose microenvironment damage.

Publisher

Research Square Platform LLC

Reference41 articles.

1. H. Sun et al., IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045, vol. 183 (DIABETES RESEARCH AND CLINICAL PRACTICE, 2022). 109119

2. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction;Lin C;EMBO Mol. Med.,2019

3. C.J. May, Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation. AMERICAN JOURNAL OF, PHYSIOLOGY-RENAL et al., PHYSIOLOGY, 2019. 317(4): p. F913-F921

4. Y. Li et al., Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism. JOURNAL OF TRANSLATIONAL MEDICINE, 2022. 20(5101)

5. Y. Yang et al., Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective. CELL DEATH & DISEASE, 2022. 13(621)